Original Article
Quinacrine in the Treatment of Discoid Lupus Erythematosus: A Five Year Follow-Up Survey — Results and Evaluation
Abstract
This five year follow-up study in the treatment of discoid lupus with quinacrine confirms other reported studies of its value. Though not universally effective, it offers help in such a high percentage of cases as to make it a drug worthy of trial in these cases.This content is limited to qualifying members.
Existing members, please login first
If you have an existing account please login now to access this article or view purchase options.
Purchase only this article ($25)
Create a free account, then purchase this article to download or access it online for 24 hours.
Purchase an SMJ online subscription ($75)
Create a free account, then purchase a subscription to get complete access to all articles for a full year.
Purchase a membership plan (fees vary)
Premium members can access all articles plus recieve many more benefits. View all membership plans and benefit packages.
